68Ga-MGS5
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-MGS5, covering 2024-07-25 to 2024-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma [Phase 1]